BRPI0606724A2 - preparação farmacêutica para contracepção - Google Patents
preparação farmacêutica para contracepçãoInfo
- Publication number
- BRPI0606724A2 BRPI0606724A2 BRPI0606724-7A BRPI0606724A BRPI0606724A2 BR PI0606724 A2 BRPI0606724 A2 BR PI0606724A2 BR PI0606724 A BRPI0606724 A BR PI0606724A BR PI0606724 A2 BRPI0606724 A2 BR PI0606724A2
- Authority
- BR
- Brazil
- Prior art keywords
- daily dose
- contraception
- dienogest
- pharmaceutical preparation
- ethinyl estradiol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
PREPARAçãO FARMACêUTICA PARA CONTRACEPçãO. A presente invenção refere-se a uma composição farmacêutica contendo dienogest em uma quantidade que na administração da composição corresponde a uma unidade de dose diária de 1,5 mg ou 2,0 mg e contendo etinilestradiol em uma quantidade que na administração da composição corresponde a uma unidade de dose diária de 0,015 mg ou 0,020 mg, juntamente com um ou mais veículos farmaceuticamente aceitáveis para pelo menos 21 unidades de doses diárias. Além disso, a invenção refere-se a um preparado farmacêutico para contracepção oral, contendo 1,5 mg de 17<244>-cianometil-17-<225>-hidroxiestra-4,9-dien-3-ona (dienogest) e 0,015 ou 0,020 mg de 17<244>-etinilestradiol (etinilestradiol) ou 2,0 mg de dienogest e 0,015 mg de etinilestradiol, juntamente com um ou mais veículos farmaceuticamente aceitáveis para pelo menos 21 unidades de doses diárias de um ciclo menstrual de 28 dias.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003179A EP1690543A1 (de) | 2005-02-15 | 2005-02-15 | Pharmazeutisches Präparat zur Kontrazeption |
| PCT/EP2006/001354 WO2006087173A1 (de) | 2005-02-15 | 2006-02-15 | Pharmazeutisches präparat zur kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0606724A2 true BRPI0606724A2 (pt) | 2009-07-14 |
Family
ID=34933759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606724-7A BRPI0606724A2 (pt) | 2005-02-15 | 2006-02-15 | preparação farmacêutica para contracepção |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1690543A1 (pt) |
| JP (1) | JP2008527018A (pt) |
| KR (1) | KR20070086380A (pt) |
| CN (1) | CN101119732A (pt) |
| AR (1) | AR053545A1 (pt) |
| AU (1) | AU2006215818A1 (pt) |
| BR (1) | BRPI0606724A2 (pt) |
| CA (1) | CA2590004A1 (pt) |
| CR (1) | CR9324A (pt) |
| DO (1) | DOP2006000035A (pt) |
| EA (1) | EA200701091A1 (pt) |
| IL (1) | IL183635A0 (pt) |
| MX (1) | MX2007009061A (pt) |
| NO (1) | NO20072687L (pt) |
| PA (1) | PA8663401A1 (pt) |
| PE (1) | PE20061291A1 (pt) |
| TW (1) | TW200640468A (pt) |
| UA (1) | UA85003C2 (pt) |
| WO (1) | WO2006087173A1 (pt) |
| ZA (1) | ZA200707910B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
| US20090099144A1 (en) * | 2007-10-11 | 2009-04-16 | Katrin Mittmann | Oral contraception (long-cycle regimen and 21-days-regimen with 30 mg ethinylestradiol and 2 mg dienogest) without treatment of thrombosis/hemostasis |
| EP2055306A1 (de) * | 2007-11-05 | 2009-05-06 | Bayer Schering Pharma AG | Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515890A (ja) * | 1996-07-26 | 2000-11-28 | アメリカン・ホーム・プロダクツ・コーポレイション | プロゲスチンとエストロゲンとの混合剤からなる一相性避妊法およびキット |
-
2005
- 2005-02-15 EP EP05003179A patent/EP1690543A1/de not_active Withdrawn
-
2006
- 2006-02-13 DO DO2006000035A patent/DOP2006000035A/es unknown
- 2006-02-15 TW TW095105106A patent/TW200640468A/zh unknown
- 2006-02-15 PE PE2006000182A patent/PE20061291A1/es not_active Application Discontinuation
- 2006-02-15 EA EA200701091A patent/EA200701091A1/ru unknown
- 2006-02-15 KR KR1020077013786A patent/KR20070086380A/ko not_active Application Discontinuation
- 2006-02-15 PA PA20068663401A patent/PA8663401A1/es unknown
- 2006-02-15 WO PCT/EP2006/001354 patent/WO2006087173A1/de active Application Filing
- 2006-02-15 JP JP2007551646A patent/JP2008527018A/ja not_active Withdrawn
- 2006-02-15 AU AU2006215818A patent/AU2006215818A1/en not_active Abandoned
- 2006-02-15 AR ARP060100527A patent/AR053545A1/es unknown
- 2006-02-15 MX MX2007009061A patent/MX2007009061A/es not_active Application Discontinuation
- 2006-02-15 CA CA002590004A patent/CA2590004A1/en not_active Abandoned
- 2006-02-15 CN CNA2006800048911A patent/CN101119732A/zh active Pending
- 2006-02-15 BR BRPI0606724-7A patent/BRPI0606724A2/pt not_active IP Right Cessation
- 2006-02-15 EP EP06706958A patent/EP1853273A1/de not_active Ceased
- 2006-02-15 UA UAA200709517A patent/UA85003C2/ru unknown
-
2007
- 2007-05-25 NO NO20072687A patent/NO20072687L/no not_active Application Discontinuation
- 2007-06-04 IL IL183635A patent/IL183635A0/en unknown
- 2007-08-17 CR CR9324A patent/CR9324A/es unknown
- 2007-09-14 ZA ZA200707910A patent/ZA200707910B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL183635A0 (en) | 2007-10-31 |
| TW200640468A (en) | 2006-12-01 |
| CR9324A (es) | 2007-10-11 |
| MX2007009061A (es) | 2007-09-11 |
| EP1853273A1 (de) | 2007-11-14 |
| AR053545A1 (es) | 2007-05-09 |
| EA200701091A1 (ru) | 2008-02-28 |
| CN101119732A (zh) | 2008-02-06 |
| PE20061291A1 (es) | 2006-12-07 |
| KR20070086380A (ko) | 2007-08-27 |
| NO20072687L (no) | 2007-11-13 |
| WO2006087173A1 (de) | 2006-08-24 |
| EP1690543A1 (de) | 2006-08-16 |
| DOP2006000035A (es) | 2006-09-15 |
| PA8663401A1 (es) | 2006-12-07 |
| UA85003C2 (ru) | 2008-12-10 |
| ZA200707910B (en) | 2009-08-26 |
| AU2006215818A1 (en) | 2006-08-24 |
| JP2008527018A (ja) | 2008-07-24 |
| CA2590004A1 (en) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
| BRPI0713565A2 (pt) | composição farmacêutica contendo ácido tetrahidrofólico | |
| ES2693085T1 (es) | Uso de estriol en bajas dosis | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| BR0213653A (pt) | Formulação farmacêutica que contém o 3-(3-dimetil-amino1-etil-2metil-propil) fenol e proporciona uma liberação retardada do ingrediente ativo | |
| BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| BR0312054A (pt) | Uso de derivados de tio-oxindol na preparação de medicamentos úteis no tratamento de condições relacionadas com hormÈnio, e kit farmacêutico | |
| BR0210595A (pt) | Regime de dosagem e composição farmacêutica para contracepção de emergência | |
| AR061959A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
| BRPI0606724A2 (pt) | preparação farmacêutica para contracepção | |
| EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| HRP20020258B1 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| CY1110348T1 (el) | Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψη | |
| SI1937274T1 (sl) | Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo | |
| UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
| RS50849B (sr) | Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu | |
| TH80558B (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
| TH80558A (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
| TH80557B (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
| TH80557A (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
| HRP20020666B1 (en) | Drospirenone for hormone replacement therapy | |
| TH54054B (th) | สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด | |
| RU2009140372A (ru) | Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |